Pseudoprimary hyperaldosteronism from topical application of 9-alpha-fluorprednisolone on the skin.
D000287:Administration, Topical; D000368:Aged; D005477:Fluprednisolone / Q000009:adverse effects* / Q000031:analogs & derivatives; D006801:Humans; D006929:Hyperaldosteronism / Q000139:chemically induced*; D007536:Isomerism; D008297:Male
C010958:9-fluoroprednisolone; D005477:Fluprednisolone